Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Search Seller Projects – ,
Asia: Japan
Japanese biopharmaceutical start-up seeks investment
The Japanese biopharmaceutical start-up is developing tumor antigen peptide vaccines and authorizing immunologic adjuvants. The tumor antigen peptide vaccines are tumor polypeptide antigens (HSP70/GPC3 peptides) which can be combined with three different types of white blood cells (HLA-A2402, HLA-A0201, HLA-A0206). The other component - immunologic adjuvants - have been recognized in clinical trials with good safety and efficacy data; it has already been applied for patent and is planning to conduct Phase 1 and Phase 2 clinical trials.
Asia: Japan
Japanese medical equipment start-up seeks USD 11.55 million E-round financing
The Japanese medical equipment start-up manufactures a variety of surgical assistance robot products. The products include endoscope gripping robots that are suitable for different types of surgeries as well as minimally invasive surgical assistance robots. Specifically speaking, the company's products incorporate tactile information sensing during operations. Through the pneumatic drive technology, the force exerted on the top of the surgical forces can be inferred, and its tactile information (such as the gripping force on organs, the pulling force during suturing, etc.) can be fed back to the chief surgeon, thereby reducing the surgical trauma to the patient. On the other hand, the maintenance cost and selling price of the company's products are lower than those of the Da Vinci surgical assistance robots, which will greatly reduce the cost of the surgery. The company's endoscope gripping robots were launched in Japan in 2015. The company is valuated at USD 143 million and seeks USD 11.55 million (JPY 1.5 billion) for E-round financing.
Asia: South Korea
Korean medical equipment company seeks USD 100 million equity financing or JV partners
The Korean medical equipment company mainly focuses on researching and manufacturing anti-fall wheelchairs, which can prevent wheelchair fall accidents. Meanwhile, the company has also launched information and communications technology products, wheelchair safety accessories and products suitable for new materials. Its wheelchair braking system has been recognized by Korea Invention Promotion Association and selected as a priority purchase item for excellent inventions. The company has won many awards including the Seoul International Invention Fair Grand Prize Award. As of 2020, more than 60 patents of the company have already been applied or are under application stage. In 2020, the company passed the Food and Drug Administration certification and has cooperated with companies such as Rehasense and Vermeiren International. Now the company seeks USD 100 million equity financing or to set up a joint venture.
Asia: South Korea
Korean cancer treatment company seeks investment
The Korean cancer treatment company has a bioelectronic nose sensor which can detect cancer earlier than other sensors or instruments on the market. The examinee only needs to exhale on the inspection machine for about 1 minute to complete the inspection, and there is no discomfort during the inspection process. At present, the company has cooperated with Seoul National University Cancer Hospital, Renji Hospital, Korea Institute of Science and Technology (KIST), etc. The company seeks investment now.
Asia: South Korea
Korean new hygroscopic polymers company seeks USD 1.68 million equity financing
The Korean new hygroscopic polymers company produces humidity controllers and dehumidifier papers. Its humidity controllers are designed through self-developed "Green & Healthy" patented technology. Its dehumidifier papers can be used for equipments and materials with special purposes, but also normal daily dehumidification needs. The company is one of the entrepreneurial ventures of the Korean Institutte of Science and Technology. Its representative director has applied for about 120 patents. Among them, 81 patents are actually registered while 31 patents are implemented. Now the company seeks USD 1.68 million for equity financing.
Asia - North Asia & China: Korea
Korean cancer treatment company seeks investment
The Korean cancer treatment company has a bioelectronic nose sensor which can detect cancer earlier than other sensors or instruments on the market. The examinee only needs to exhale on the inspection machine for about 1 minute to complete the inspection, and there is no discomfort during the inspection process. At present, the company has cooperated with Seoul National University Cancer Hospital, Renji Hospital, Korea Institute of science and Technology (KIST), etc. The company seeks investment now.
Asia - North Asia & China: Korea
Korean digital economy media company seeks USD 8.4 million investment.
The Korean company is a digital economy media enterprise established in 2018, providing real-time market information, news, and analysis of virtual assets, through various types of interviews. The company uses the information to help customers analyze and get solutions. Now, the company seeks USD 8.4 million for equity financing.
Asia - North Asia & China: Korea
Korean AI medical diagnosis firm seeks USD 2.5 million investment
The Korean AI medical company's products include a cervical cancer diagnosis AI system, an early AI diagnosis for stroke risk, a stroke risk prediction AI system based ob carotid ultrasound images, and a cerebral aneurysm rupture risk prediction AI system based on cerebral angiography images. The company has developed a international system with various languages to ensure that all medical personnel around the world can use its AI diagnosis solutions. Its partners include Swedish medical device manufacturer Gynius plus AB and Canadian health care company Variational AI. The company seeks USD 2.5 million for equity financing.
Asia - North Asia & China: Korea
Korea condiment company seeks USD 10 million investment
The Korean condiment company has successfully extracted salt from Salicornia, a halophyte flowering plant containing a large amount of salt, and developed the world's first plant based salt with 100% purity. A natural low-sodium salt, which can reduce sodium intake by 20% and have a significant effect on hypertension. The company also desalinated Salicornia and developed a new food that can effectively reduce body fat. In addition, the company developed healthy functional food materials and tea drinks that can effectively improve memory and cognitive ability by using Salicornia. It has 35 patents for Salicornia-based products. The company's round B equity financing seeks USD 10 million.
Middle East: Israel
Israeli medical equipment company seeks strategic partners and investment.
The Israeli medical equipment company has several innovative products. These products include drug delivery catheters (any drug, specific dose, platform technology), Vascular transplantation equipment, and special needles. The company seeks strategic partners and investment.
Middle East: Israel
Israeli company focuses on Ophthalmology seeks investment.
The Israeli company focuses on Ophthalmology and has a project which on a diagnostic solution that can provide multi-parameter, objective, rapid, simple, and semi quantitative tear film analysis to identify one or more potential causes. The project may not only become a clinically valuable real-time test, but also an auxiliary diagnostic test to meet the needs of rapid diagnosis and personalized medical treatment. The project is a cost-effective, easy-to-use, and objective solution that will enable eye care professionals to diagnose and treat patients, including patients who may not be diagnosed or whose condition remain uncertain. The company has completed three clinical trials in the United States and plans to carry out key trials with FDA. Now, the company seeks investment.
Middle East: Israel
Israeli medical company seeks investment for its Ophthalmic project.
The Israeli medical company is a joint venture, which authorizes the use of non-invasive local drug delivery technology, which is used to treat posterior ocular diseases by eye drops instead of current drug delivery methods (such as intravitreal injection). The platform technology can also be used for eye treatment. The project is currently in the preclinical stage of the development of a few candidate products. The company seeks investment for this project.
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us